Takeaways: Health Canada’s approval of Fujirebio’s Lumipulse G NfL Blood and pTau217 Plasma assays brings two high‑demand, blood‑based neurology tests into the Canadian marke...
Felix Health launches sleep apnea care in Canada through collaboration with MedSleep Felix Health announced the launch of sleep apnea care across Ontario, British Columbia, and Alberta through a new c...
Takeaways: The Canadian government’s funding supports Kardium’s plan to expand manufacturing and cleanroom capacity in Vancouver, enabling the company to scale production of its Globe Pulsed Fie...
Takeaways: The launch expands Olympus’ footprint in the growing open-surgery vessel-sealing segment and reinforces its platform strategy, making it easier for hospitals to standardiz...
Takeaways: Felix’s sleep apnea program, built with MedSleep, creates a virtual front door for one of Canada’s most under‑diagnosed chronic conditions (≈1 in 4 adults at high risk, only ~3%...
Bayer’s LYNKUET (elinzanetant) receives expanded authorization in Canada for breast cancer-related vasomotor symptoms Bayer Canada announced that Health Canada has expanded the market authorizat...
Takeaways: Knight Therapeutics’ Canadian launch of WYNZORA strengthens its dermatology portfolio and marks the commercialization of a product it inherited through the Paladin acquisition. The launch a...
Takeaways: Health Canada’s approval of ZORYVE cream 0.05% extends Arcutis’ topical atopic dermatitis franchise into the preschool population, addressing a treatment gap in a disease that frequently be...
Takeaways: Silo Pharma’s CIPO Notice of Allowance for SPC‑15 strengthens its IP moat around a prophylactic, intranasal 5‑HT4 agonist approach for PTSD and stress‑induced disorders, complementing a rec...
Takeaways: Roche Canada’s completion of pCPA negotiations for Perjeta (pertuzumab) in the neoadjuvant setting (with trastuzumab + chemotherapy) for HER2‑positive, locally advanced, inflammatory...